Pharmacy |
| ||
|
Cyclogyl Eye Drops Generic Cyclopentolate Hydrochloride |
|
| ||
Home » Prescription Drugs 5 » Cyclogyl Eye Drops Generic Cyclopentolate Hydrochloride IndicationsFor mydriasis and cycloplegia in diagnostic procedures. For some pre- and post-operative states when mydriasis is required and when a shorter acting mydriatic and cycloplegic is needed in the therapy of iridocyclitis.Dosage and Administration:AdultsOne drop followed by a second drop in 5 minutes.Complete recovery usually occurs in 24 hours.ChildrenOne drop is instilled in each eye followed 5 minutes later by a second application if necessary.Pretreatment with CYCLOGYL Eye Drops on the day prior to examination usually is not necessary.In order to minimise systemic absorption apply pressure to the tear duct for two minutes immediately after administration. Buy Cyclogyl Eye Drops Generic Cyclopentolate Hydrochloride and other Prescription Drugs 5 products online at Medstore. 5481
About Cyclogyl Eye Drops Generic Cyclopentolate Hydrochloride: Product Type: Prescription Drugs 5 Cyclogyl Eye Drops ( Generic Cyclopentolate Hydrochloride ) Cyclogyl Eye Drops (Generic Cyclopentolate Hydrochloride) Generic Cyclopentolate Hydrochloride 1% 15mL Generic Cyclopentolate Hydrochloride Cyclogyl Eye Drops
View more Prescription Drugs 5 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
